HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,525-1,536 of 1,979
Drug study icon
CompletedEUCTR 2012-001341-41

Propofol vs. Ketamin

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
Bipolarity, DepressionHistorical research record
Countries
Austria
Sponsor
Universitätsklinik für Psychiatrie und Psychotherapie I
Drug study icon
CompletedEUCTR 2022-000034-42

The Estimated 12-Hour Serum Lithium Level Pilot Study

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Denmark
Bipolarity, DepressionHistorical research record
Countries
Denmark
Sponsor
Aarhus University Hospital - Psychiatry, Department of Affective Disorders
Drug study icon
Recruitment unclearEUCTR 2004-001308-11

Optimal Treatment Duration with Olanzapine following Remission of Manic or Mixed Episode. An Open-Label, Randomized Trial Comparing Two Treatment Strategies

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Spain
Bipolarity, DepressionHistorical research record
Countries
Spain
Sponsor
Lilly.S.A.
Drug study icon
Not recruitingEUCTR 2021-002108-11

A 12-Month Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Effectiveness of SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated ...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Depression, BipolarityHistorical research record
Countries
Bulgaria, Croatia, Slovakia
Sponsor
Sunovion Pharmaceuticals Inc.
Drug study icon
Not recruitingEUCTR 2009-016648-38

A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With ...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Depression, BipolarityHistorical research record
Countries
France, Bulgaria, Finland, + 5 others
Sponsor
Cephalon, Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.